KYTX
Price
$8.25
Change
-$0.10 (-1.20%)
Updated
Sep 4 closing price
Capitalization
510.83M
74 days until earnings call
Intraday BUY SELL Signals
MENS
Price
$2.39
Change
+$0.12 (+5.29%)
Updated
Sep 4 closing price
Capitalization
177.42M
Intraday BUY SELL Signals
Interact to see
Advertisement

KYTX vs MENS

KYTX vs MENS Comparison Chart in %
View a ticker or compare two or three
VS
KYTX vs. MENS commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a Hold and MENS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2026
Stock price -- (KYTX: $8.25 vs. MENS: $2.39)
Brand notoriety: KYTX and MENS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 50% vs. MENS: 115%
Market capitalization -- KYTX: $510.83M vs. MENS: $177.42M
KYTX [@Biotechnology] is valued at $510.83M. MENS’s [@Biotechnology] market capitalization is $177.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 0 FA rating(s) are green whileMENS’s FA Score has 1 green FA rating(s).

  • KYTX’s FA Score: 0 green, 5 red.
  • MENS’s FA Score: 1 green, 4 red.
According to our system of comparison, MENS is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 4 TA indicator(s) are bullish while MENS’s TA Score has 5 bullish TA indicator(s).

  • KYTX’s TA Score: 4 bullish, 6 bearish.
  • MENS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MENS is a better buy in the short-term than KYTX.

Price Growth

KYTX (@Biotechnology) experienced а -1.43% price change this week, while MENS (@Biotechnology) price change was +0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

KYTX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($511M) has a higher market cap than MENS($177M). KYTX YTD gains are higher at: -12.234 vs. MENS (-42.532).
KYTXMENSKYTX / MENS
Capitalization511M177M289%
EBITDA-153.62MN/A-
Gain YTD-12.234-42.53229%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash236MN/A-
Total Debt33.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
KYTXMENS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
90%
Bullish Trend 8 days ago
90%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
KYTX
Daily Signal:
Gain/Loss:
MENS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMCFX14.580.24
+1.67%
Royce Micro-Cap Svc
MINFX43.86N/A
N/A
MFS International Intrinsic Equity R2
CSECX18.73N/A
N/A
Calvert Equity C
CSVIX32.93N/A
N/A
Calvert Small-Cap I
WDIAX17.28N/A
N/A
Wilmington Enhanced Div Inc Strat A